Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-393

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 55150-393). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Azacitidine-figure-1 (Azacitidine Fig1)

Azacitidine-figure-1 (Azacitidine Fig1)
The text is displaying the results of a study. It shows a comparison between two treatments (Aza and CCR) for a certain condition over a period of 40 months. The results indicate that the Log-Rank p-value is 0.0001, meaning that there is a significant difference between the two treatments. The Hazard Ratio (HR) is 0.58, with a 95% Confidence Interval of 0.43 to 0.77. It also indicates the number of deaths for each group (82 for Aza and 113 for CCR). There is further data presented in a graph, with the x-axis representing time in months, and the y-axis representing survival probability. The graph shows that the survival rate for Aza is higher than CCR. The text also presents the number of patients that were alive at different points in time for each treatment group.*
FDA Label Image

Package Label-principal Display Panel-100 mg Per Vial (Container Label)

Package Label-principal Display Panel-100 mg Per Vial (Container Label)
This is a description of a medication with the NDC code 55150-393-01. It is a sterile single-dose vial that contains azacitidine 100mg and mannitol 100mg, which are used for subcutaneous and intravenous injection. The prescribing information should be consulted for the usual dosage and administration details. Any unused portion of the medication in the single-dose vial should be discarded, and it should be kept out of reach of children. The medication should be stored at 25°C with excursions permitted to 15° to 30°C and is a cytotoxic agent. The medication is manufactured in India for Eugia US LLC based in New Jersey, USA.*
FDA Label Image

Package Label-principal Display Panel-100 mg Per Vial (Container-Carton (1 Vial))

Package Label-principal Display Panel-100 mg Per Vial (Container-Carton (1 Vial))
Azacitidine is a cytotoxic agent provided in a 100 mg single-dose vial for subcutaneous and intravenous use only. The vial has azacitidine 100 mg and mannitol 100 mg, and the usual dosage should be seen in the prescribing information for dosing and administration. The vial stopper is not made with natural rubber latex, and the unused portion should be discarded. It is distributed by Eugia USLLC and made in India. It should be kept at 25°C (7°F) with permitted excursions to 15°to 30°C (5 to 86°F) and out of reach of children.*
FDA Label Image

Chemical Structure (Azacitidine Str)

Chemical Structure (Azacitidine Str)
This is not-available. The given text is a combination of chemical symbols and formulas without context, making it impossible to generate a meaningful description.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.